scholarly journals Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes

2021 ◽  
Vol 37 (1) ◽  
pp. 86-93 ◽  
Author(s):  
Mohamed Osama Mohamed ◽  
Tahmeed Contractor ◽  
Donah Zachariah ◽  
Harriette G.C. van Spall ◽  
Purvi Parwani ◽  
...  
Keyword(s):  
Cardiac Resynchronization Therapy ◽  
Cardiac Resynchronization ◽  
Resynchronization Therapy ◽  
Sex Disparities ◽  
Cardiac Resynchronization Therapy Device

scholarly journals B-PO03-192 REDUCTION IN QRS AREA CORRELATES WITH HEMODYNAMIC RESPONSE DURING CARDIAC RESYNCHRONIZATION THERAPY - DEVICE IMPLANTATION

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S267
Author(s):  
Mohammed Ali Ghossein ◽  
Antonius M.W. van Stipdonk ◽  
Floor CWM. Salden ◽  
Elien B. Engels ◽  
Francesco Zanon ◽  
...  
Keyword(s):  
Cardiac Resynchronization Therapy ◽  
Hemodynamic Response ◽  
Cardiac Resynchronization ◽  
Resynchronization Therapy ◽  
Device Implantation ◽  
Cardiac Resynchronization Therapy Device

scholarly journals Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study

2017 ◽  
Vol 55 (3) ◽  
pp. 139-144 ◽  
Author(s):  
Morteza Safi ◽  
Mohammad Ali Akbarzadeh ◽  
Azadeh Azinfar ◽  
Mohammad Hasan Namazi ◽  
Isa Khaheshi
Keyword(s):  
Cardiac Resynchronization Therapy ◽  
Cardiac Pacemaker ◽  
Cardiac Resynchronization ◽  
Resynchronization Therapy ◽  
Venous Obstruction ◽  
Icd Implantation ◽  
Total Occlusion ◽  
Icd Leads ◽  
Increased Risk ◽  
Cardiac Resynchronization Therapy Device

Abstract Background. Obstruction of the access vein following cardiac pacemaker and defibrillator implantation is a common complication. However, the exact incidence and contributing risk factors are unknown. The aim of this study is to determine the incidence and analyze the contribution of each risk factor. Methods. 57 consecutive patients candidate for their first transvenous pacemaker, implantable cardioverter-defibrillator (ICD), or cardiac resynchronization therapy device implantation were enrolled. After implantation, venography of the ipsilateral peripheral arm was performed. Patients underwent their second venography after the follow-up period of 3 to 6 months. Results. 42 patients (13 females, mean age 59.71 ± 12.33) completed the study. The followup venography showed significant venous obstruction (more than 50%) in 9 (21%) patients, but in none of the individuals, venography revealed total occlusion of the veins. Patients with obstruction had more leads in their veins (2.56 ± 0.53 vs 1.58 ± 0.71, P = 0.001). Venous obstruction was significantly more prevalent in patients with implanted cardiac resynchronization therapy device compared with an ICD or pacemaker (p = 0. 01). Age, gender, diabetes mellitus, hypertension, ischemic heart disease and antiplatelet consumption did not reveal any other contribution to the risk of thrombosis. In multivariate analysis, total lead number was a positive predictor for venous occlusion (P = 0.015, OR:19.2, and CI: 1.7-207.1). Conclusion. Venous obstruction is relatively frequent after pacemaker or ICD implantation. This study also shows that pacemaker and ICD leads have a similar risk for lead-related venous obstruction. However, patients with multiple leads are associated with an increased risk.

Sign in / Sign up

Export Citation Format

Share Document